MetaADEDB 2.0 @ LMMD
Deferiprone
(TZXKOCQBRNJULO-UHFFFAOYSA-N)
Structure
SMILES
Cn1ccc(=O)c(c1C)O
Type(s)
Approved
ATC code(s)
V03AC02
Molecular Formula:
C7H9NO2
Molecular Weight:
139.152
Log P:
0.3993
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
1
TPSA:
42.23
CAS Number(s):
30652-11-0
Synonym(s)
1.
Deferiprone
2.
1,2-Dimethyl-3-hydroxy-4-pyridinone
3.
1,2-Dimethyl-3-hydroxypyrid-4-one
4.
1,2-Dimethyl-3-hydroxypyridin-4-one
5.
3-Hydroxy-1,2-dimethyl-4-pyridinone
6.
DMOHPO
7.
Ferriprox
8.
HDMPP
9.
1,2 Dimethyl 3 hydroxy 4 pyridinone
10.
1,2 Dimethyl 3 hydroxypyrid 4 one
11.
1,2 Dimethyl 3 hydroxypyridin 4 one
12.
3 Hydroxy 1,2 dimethyl 4 pyridinone
External Link(s)
MeSHD000077543
PubChem Compound2972
ChEBI68554
CHEMBLCHEMBL70927
DrugBankDB08826
DrugCentral4188
IUPHAR/BPS Guide to PHARMACOLOGY7456
KEGGdr:D07416
Therapeutic Target DatabaseD0N0OU
ZINC6226
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AgranulocytosisFAERS: 40
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
2NeutropeniaFAERS: 21
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
3NauseaFAERS: 14
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
4ArthralgiaFAERS: 11SIDER
US FAERS
5VomitingFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
6FatigueFAERS: 8
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
7PneumoniaFAERS: 8
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
8White blood cell count decreasedFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
9InfectionFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
10LeukopeniaFAERS: 6US FAERS
11MyalgiaFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
12SepsisFAERS: 6
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
13Febrile NeutropeniaFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
14PainFAERS: 5
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
15ThrombocytopeniaFAERS: 5US FAERS
16ArthritisFAERS: 4SIDER
US FAERS
17AstheniaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
18Back PainFAERS: 4SIDER
US FAERS
19ChillsFAERS: 4SIDER
US FAERS
20DizzinessFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
21HypotensionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
22MalaiseFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
23Neutrophil count decreasedFAERS: 4SIDER
US FAERS
24SomnolenceFAERS: 4SIDER
US FAERS
25Abdominal discomfortFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
26Cerebrovascular accidentFAERS: 3US FAERS
27HypertransaminasaemiaFAERS: 3US FAERS
28MastectomyFAERS: 3US FAERS
29PharyngitisFAERS: 3SIDER
US FAERS
30UrticariaFAERS: 3SIDER
US FAERS
31AgitationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
32Back disorderFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
33HyperpyrexiaFAERS: 2US FAERS
34MiliariaFAERS: 2US FAERS
35Oropharyngeal painFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
36Persistent depressive disorderFAERS: 2US FAERS
37School refusalFAERS: 2US FAERS
38Separation Anxiety DisorderFAERS: 2US FAERS
39SinusitisFAERS: 2US FAERS
40TachycardiaFAERS: 2US FAERS
41Toxicity to various agentsFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
42Unevaluable eventFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
43AbscessFAERS: 1US FAERS
44Alanine Aminotransferase IncreasedFAERS: 1SIDER
US FAERS
45Anal FistulaFAERS: 1US FAERS
46Ankle FractureFAERS: 1US FAERS
47Aspartate Aminotransferase IncreasedFAERS: 1SIDER
US FAERS
48AsthmaFAERS: 1US FAERS
49Atrial FibrillationFAERS: 1SIDER
US FAERS
50BabesiosisFAERS: 1US FAERS
51Bone painFAERS: 1US FAERS
52Breech PresentationFAERS: 1US FAERS
53BronchitisFAERS: 1US FAERS
54Cardiac ArrestFAERS: 1US FAERS
55Catheter site infectionFAERS: 1US FAERS
56CellulitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
57Chest PainFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
58CholestasisFAERS: 1US FAERS
59Clostridium difficile colitisFAERS: 1US FAERS
60ConstipationFAERS: 1US FAERS
61CystFAERS: 1US FAERS
62Cytomegalovirus test positiveFAERS: 1US FAERS
63DiplopiaFAERS: 1SIDER
US FAERS
64Disease ProgressionFAERS: 1US FAERS
65EpilepsyFAERS: 1US FAERS
66EpistaxisFAERS: 1SIDER
US FAERS
67ErythemaFAERS: 1US FAERS
68Euphoric moodFAERS: 1US FAERS
69Feeling abnormalFAERS: 1US FAERS
70GastritisFAERS: 1US FAERS
71General physical health deteriorationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
72Gingival HypertrophyFAERS: 1US FAERS
73Hospice CareFAERS: 1US FAERS
74HypersplenismFAERS: 1SIDER
US FAERS
75Incorrect dose administeredFAERS: 1US FAERS
76InflammationFAERS: 1US FAERS
77Injection site infectionFAERS: 1US FAERS
78Intestinal ObstructionFAERS: 1US FAERS
79Iron OverloadFAERS: 131542421CTD
US FAERS
80Leptotrichia infectionFAERS: 1US FAERS
81LymphadenitisFAERS: 1US FAERS
82LymphomaFAERS: 1US FAERS
83LymphopeniaFAERS: 1US FAERS
84MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
85Malignant neoplasm progressionFAERS: 1US FAERS
86MalnutritionFAERS: 1SIDER
US FAERS
87Medical device changeFAERS: 1US FAERS
88MyoclonusFAERS: 1US FAERS
89NasopharyngitisFAERS: 1US FAERS
90NephroptosisFAERS: 1US FAERS
91Noninfective gingivitisFAERS: 1US FAERS
92Oral infectionFAERS: 1US FAERS
93OverdoseFAERS: 1US FAERS
94PancytopeniaFAERS: 1SIDER
US FAERS
95PolyarthritisFAERS: 1US FAERS
96Pre-existing condition improvedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
97Procedural complicationFAERS: 1US FAERS
98PruritusFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
99Pulmonary EmbolismFAERS: 1SIDER
US FAERS
100Rhinovirus infectionFAERS: 1US FAERS
101Soft Tissue InfectionFAERS: 1US FAERS
102Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
103ThrombosisFAERS: 1US FAERS
104Tooth InfectionFAERS: 1US FAERS
105Transaminases increasedFAERS: 1US FAERS
106Urethral fistulaFAERS: 1US FAERS
107Urinary tract infectionFAERS: 1US FAERS
108Visual ImpairmentFAERS: 1US FAERS
109Weight decreasedFAERS: 1US FAERS
110Abdominal PainSIDER
111Anaphylactic shockSIDER
112ArthropathySIDER
113Blood and lymphatic system disordersSIDER
114BruxismSIDER
115Cardiomyopathies18298856CTD
116Cardiovascular Diseases16339662CTD
117ChromaturiaSIDER
118Cryptococcal cutaneous infectionSIDER
119DehydrationSIDER
120DermatitisSIDER
121DisabilitySIDER
122DiscomfortSIDER
123Drug ineffectiveCanada Vigilance: 3Canada Vigilance
124DyspepsiaSIDER
125EncephalitisSIDER
126EnterocolitisSIDER
127FibrosisSIDER
128Friedreich Ataxia23418481CTD
129Gastric ulcerSIDER
130Gastrointestinal PainSIDER
131GlycosuriaSIDER
132HeadacheSIDER
133Hepatitis CSIDER
134HepatitisSIDER
135HepatomegalySIDER
136HypersensitivitySIDER
137InfestationSIDER
138Metabolic acidosisSIDER
139Muscle SpasticityCanada Vigilance: 1Canada Vigilance
140Muscle relaxant therapySIDER
141Musculoskeletal discomfortSIDER
142MyositisSIDER
143NystagmusSIDER
144Obsessive-Compulsive DisorderSIDER
145Optic NeuritisSIDER
146PancreatitisSIDER
147Psychomotor skills impairedSIDER
148Retinal toxicitySIDER
149Subcutaneous AbscessSIDER
150ThrombocytosisSIDER
151TrismusSIDER
152Ventricular Dysfunction, Left16798648
18298856
31542421
CTD
153effusionSIDER
154furuncleSIDER
155jaundiceSIDER
156nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.